Filtros de búsqueda

Lista de obras de

A Case of Disseminated Infection with Skin Manifestation due to Non-neoformans and Non-gattii Cryptococcus in a Patient with Refractory Acute Myeloid Leukemia ⬇️

artículo científico publicado en 2017

A Phase I/II, Open-Label, Prospective, Multicenter Study to Evaluate the Efficacy and Safety of Lower Doses of Bortezomib Plus Busulfan and Melphalan as a Conditioning Regimen in Patients with Multiple Myeloma Undergoing Autologous Peripheral Blood

scientific article published on 23 March 2019

A multicenter phase II trial of etoposide, methylprednisolone, high-dose cytarabine, and oxaliplatin for patients with primary refractory/relapsed aggressive non-Hodgkin's lymphoma

artículo científico publicado en 2008

A phase I study of everolimus and CHOP in newly diagnosed peripheral T-cell lymphomas

artículo científico publicado en 2013

A phase II study of etoposide, methylprednisolone, high-dose cytarabine, and oxaliplatin (ESHAOx) for patients with refractory or relapsed Hodgkin's lymphoma

artículo científico publicado en 2020

A phase II study of oxaliplatin and prednisone for patients with relapsed or refractory marginal zone lymphoma: Consortium for Improving Survival of Lymphoma trial

artículo científico publicado en 2015

ABCG2 Q141K polymorphism is associated with chemotherapy-induced diarrhea in patients with diffuse large B-cell lymphoma who received frontline rituximab plus cyclophosphamide/doxorubicin/vincristine/prednisone chemotherapy

artículo científico publicado en 2008

Absence of IDH2 codon 172 mutation in common human cancers.

artículo científico publicado en 2009

Absence of oncogenic AKT1 E17K mutation in prostate, esophageal, laryngeal and urothelial carcinomas, hepatoblastomas, gastrointestinal stromal tumors and malignant meningiomas

artículo científico publicado en 2009

Adenovirus expressing both thymidine kinase and soluble PD1 enhances antitumor immunity by strengthening CD8 T-cell response

artículo científico publicado en 2013

Adverse prognostic impact of bone marrow microvessel density in multiple myeloma

artículo científico publicado en 2015

Adverse prognostic impact of vascular endothelial growth factor gene polymorphisms in patients with diffuse large B-cell lymphoma

artículo científico publicado en 2017

Allogeneic Stem Cell Transplantation for Patients with Natural Killer/T Cell Lymphoid Malignancy: A Multicenter Analysis Comparing Upfront and Salvage Transplantation

artículo científico publicado en 2018

Analysis of NOTCH1 extracellular juxtamembrane expansion mutations in acute leukemias and multiple myelomas

artículo científico publicado en 2009

Analysis of factors associated with successful allogeneic peripheral blood stem cell collection in healthy donors

scientific article published on 24 November 2019

Analysis of laboratory parameters for optimal autologous peripheral blood stem cell collection from lymphoma and myeloma patients

artículo científico publicado en 2020

Analysis of the Efficacy of Thalidomide Plus Dexamethasone-Based Regimens in Patients With Relapsed/Refractory Multiple Myeloma Who Received Prior Chemotherapy, Including Bortezomib and Lenalidomide: KMM-166 Study

scientific article published on 31 October 2019

Autologous stem cell transplantation in elderly patients with multiple myeloma in Korea: the KMM1807 study

scientific article published on 25 May 2020

Bendamustine in heavily pre-treated multiple myeloma patients: Results of a retrospective analysis from the Korean Multiple Myeloma Working Party

artículo científico publicado en 2016

Bortezomib, thalidomide, dexamethasone induction therapy followed by melphalan, prednisolone, thalidomide consolidation therapy as a first line of treatment for patients with multiple myeloma who are non-transplant candidates: results of the Korean

scientific article published on 10 December 2009

Brief report: Clinical experiences after emergency use of daratumumab monotherapy for relapsed or refractory multiple myeloma in real practice

scientific article published on 01 January 2019

CTLA4-CD28 chimera gene modification of T cells enhances the therapeutic efficacy of donor lymphocyte infusion for hematological malignancy

artículo científico publicado en 2017

Chromosome 13 deletion and hypodiploidy on conventional cytogenetics are robust prognostic factors in Korean multiple myeloma patients: web-based multicenter registry study

artículo científico publicado en 2014

Chromothripsis in Treatment Resistance in Multiple Myeloma

artículo científico publicado en 2017

Clathrin assembly lymphoid myeloid leukemia-AF10-positive acute leukemias: a report of 2 cases with a review of the literature.

artículo científico publicado en 2010

Clinical Implications of Quantitative JAK2 V617F Analysis using Droplet Digital PCR in Myeloproliferative Neoplasms

artículo científico publicado en 2018

Clinical factors associated with response or survival after chemotherapy in patients with Waldenström macroglobulinemia in Korea

artículo científico publicado en 2014

Clinical features and outcomes of Hodgkin's lymphoma in Korea: Consortium for Improving Survival of Lymphoma (CISL)

artículo científico publicado en 2011

Clinical features and prognostic relevance of ovarian involvement in non-Hodgkin's lymphoma: A Consortium for Improving Survival of Lymphoma (CISL) report

artículo científico publicado en 2010

Clinical features and survival outcomes in patients with multiple myeloma: analysis of web-based data from the Korean Myeloma Registry

artículo científico publicado en 2009

Clinical features and treatment outcomes of limited-stage mantle cell lymphoma: Consortium for Improving Survival of Lymphoma report

scientific article published on 18 December 2019

Clinical impact of frailty on treatment outcomes of elderly patients with relapsed and/or refractory multiple myeloma treated with lenalidomide plus dexamethasone

artículo científico publicado en 2020

Clinical outcomes and prognostic factors in patients with breast diffuse large B cell lymphoma; Consortium for Improving Survival of Lymphoma (CISL) study

artículo científico publicado en 2010

Clinical outcomes in patients with diffuse large B cell lymphoma with a partial response to first-line R-CHOP chemotherapy: prognostic value of secondary International Prognostic Index scores and Deauville scores.

artículo científico

Comparable Analysis of Outcomes for Allogeneic Peripheral Blood Stem Cell Transplantation from Matched Related and Matched Unrelated Donors in Acute Myeloid Leukemia ⬇️

artículo científico publicado el 6 de diciembre de 2011

Comparative analysis of outcomes of allogeneic peripheral blood stem cell transplantation from related and unrelated donors

artículo científico

Comparison of Two Apheresis Systems of COBE and Optia for Autologous Peripheral Blood Stem Cell Collection

artículo científico publicado en 2017

Comparison of spectra optia and amicus cell separators for autologous peripheral blood stem cell collection

artículo científico publicado en 2020

Comprehensive Evaluation of the Revised International Staging System in Multiple Myeloma Patients Treated with Novel Agents as a Primary Therapy.

artículo científico

Concurrent chemoradiotherapy followed by L-asparaginase-containing chemotherapy, VIDL, for localized nasal extranodal NK/T cell lymphoma: CISL08-01 phase II study.

artículo científico publicado en 2014

Consideration of aggressive therapeutic strategies for primary testicular lymphoma

artículo científico publicado en 2007

Correction to: Clinical outcomes in patients with diffuse large B cell lymphoma with a partial response to first-line R-CHOP chemotherapy: prognostic value of secondary International Prognostic Index scores and Deauville scores

artículo científico publicado en 2020

Current Treatment Patterns and Outcomes in Patients with Peripheral T-Cell Lymphoma: Updated Results of the Nationwide, Multi-Center Prospective Registry Study (CISL 1404)

Cyclosporine A in the treatment of a patient with immune thrombocytopenia accompanied by myelodysplastic syndrome and nephrotic syndrome

artículo científico publicado en 2003

DNA repair gene XRCC1 polymorphisms and haplotypes in diffuse large B-cell lymphoma in a Korean population.

artículo científico publicado en 2010

Detection of circulating lymphoma cells in patients with non-Hodgkin lymphoma using MAGE-A3 gene expression in peripheral blood

artículo científico publicado en 2009

Development of an Automated Image Analyzer for Microvessel Density Measurement in Bone Marrow Biopsies

artículo científico publicado en 2020

Early determination of prognosis by interim 3'-deoxy-3'-18F-fluorothymidine PET in patients with non-Hodgkin lymphoma

artículo científico publicado en 2013

Early response to bortezomib combined chemotherapy can help predict survival in patients with multiple myeloma who are ineligible for stem cell transplantation.

artículo científico publicado en 2013

Efficacy and toxicity of the combination chemotherapy of thalidomide, alkylating agent, and steroid for relapsed/refractory myeloma patients: a report from the Korean Multiple Myeloma Working Party (KMMWP) retrospective study

artículo científico publicado en 2016

Efficacy of Brentuximab Vedotin in Relapsed or Refractory High-CD30-Expressing Non-Hodgkin Lymphomas: Results of a Multicenter, Open-Labeled Phase II Trial

artículo científico publicado en 2019

Efficacy of eculizumab in paroxysmal nocturnal hemoglobinuria patients with or without aplastic anemia: prospective study of a Korean PNH cohort

artículo científico publicado en 2017

Elevated red blood cell distribution width as a simple prognostic factor in patients with symptomatic multiple myeloma

artículo científico publicado en 2014

Escalated daunorubicin dosing as an induction treatment for Philadelphia-negative adult acute lymphoblastic leukemia.

artículo científico

Expression of myeloid antigen in neoplastic plasma cells is related to adverse prognosis in patients with multiple myeloma

artículo científico publicado en 2014

First-Line Treatment for Primary Breast Diffuse Large B-Cell Lymphoma Using Immunochemotherapy and Central Nervous System Prophylaxis: A Multicenter Phase 2 Trial

artículo científico publicado en 2020

Frontline rituximab, cyclophosphamide, doxorubicin, and prednisone with bortezomib (VR-CAP) or vincristine (R-CHOP) for non-GCB DLBCL.

artículo científico publicado en 2015

Glutathione-S-transferase genotypes influence the risk of chemotherapy-related toxicities and prognosis in Korean patients with diffuse large B-cell lymphoma

artículo científico publicado en 2010

Hepatitis B virus reactivation in B-cell lymphoma patients treated with rituximab: analysis from the Asia Lymphoma Study Group

artículo científico publicado en 2013

Highly elevated serum lactate dehydrogenase is associated with central nervous system relapse in patients with diffuse large B-cell lymphoma: Results of a multicenter prospective cohort study

artículo científico publicado en 2016

Host MHC class II+ antigen-presenting cells and CD4 cells are required for CD8-mediated graft-versus-leukemia responses following delayed donor leukocyte infusions

artículo científico publicado en 2006

Identification of hypoxanthine as a urine marker for non-Hodgkin lymphoma by low-mass-ion profiling

artículo científico publicado en 2010

Improved prognostic stratification using NCCN- and GELTAMO-international prognostic index in patients with diffuse large B-cell lymphoma

artículo científico publicado en 2017

Interleukin-10 Polymorphisms in Association with Prognosis in Patients with B-Cell Lymphoma Treated by R-CHOP.

scientific article published on 30 December 2016

Intravenous busulfan and melphalan versus high-dose melphalan as a conditioning regimen for early autologous stem cell transplantation in patients with multiple myeloma: a propensity score-matched analysis

artículo científico publicado en 2020

Lenalidomide with dexamethasone treatment for relapsed/refractory myeloma patients in Korea-experience from 110 patients.

artículo científico

Long-term follow-up of imatinib plus combination chemotherapy in patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia

artículo científico

Low-dose cisplatin converts the tumor microenvironment into a permissive state for HSVtk-induced antitumor immunity in HPV16-related tonsillar carcinoma

artículo científico publicado en 2014

Lymphopenia is an important prognostic factor in peripheral T-cell lymphoma (NOS) treated with anthracycline-containing chemotherapy

artículo científico publicado en 2011

Matched‐pair analysis comparing the outcomes of primary breast and nodal diffuse large B‐cell lymphoma in patients treated with rituximab plus chemotherapy ⬇️

artículo científico publicado el 30 de agosto de 2011

Multicenter Phase II Study of Bendamustine Plus Rituximab in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma ⬇️

artículo científico publicado el 6 de mayo de 2013

Multicenter analysis of treatment outcomes in adult patients with lymphoblastic lymphoma who received hyper-CVAD induction followed by hematopoietic stem cell transplantation.

artículo científico

Multiple mucosa-associated lymphoid tissue organs involving marginal zone B cell lymphoma: organ-specific relationships and the prognostic factors. Consortium for improving survival of lymphoma study ⬇️

artículo científico publicado el 14 de septiembre de 2010

Multiple myeloma in Korea: past, present, and future perspectives. Experience of the Korean Multiple Myeloma Working Party.

artículo científico publicado en 2010

Mutational analysis of EZH2 codon 641 in non-Hodgkin lymphomas and leukemias ⬇️

artículo científico publicado el 21 de septiembre de 2010

Mutational analysis of UBR5 gene encoding an E3 ubiquitin ligase in common human cancers.

artículo científico publicado en 2010

Nationwide Statistical Analysis of Lymphoid Malignancies in Korea

artículo científico publicado en 2017

Nationwide statistical analysis of myeloid malignancies in Korea: incidence and survival rate from 1999 to 2012.

artículo científico publicado en 2015

Neural stem cell transplant survival in brains of mice: assessing the effect of immunity and ischemia by using real-time bioluminescent imaging

artículo científico publicado en 2006

Nilotinib combined with multiagent chemotherapy for newly diagnosed Philadelphia-positive acute lymphoblastic leukemia

artículo científico

Oncogenic NRF2 mutations in squamous cell carcinomas of oesophagus and skin

artículo científico publicado en 2010

Phase 2 Study of an Intravenous Busulfan and Melphalan Conditioning Regimen for Autologous Stem Cell Transplantation in Patients with Multiple Myeloma (Kmm150).

artículo científico publicado en 2018

Phase I Clinical Trial of 4-1BB-based Adoptive T-Cell Therapy for Epstein-Barr Virus (EBV)-positive Tumors

artículo científico publicado en 2016

Phase I study of CKD-581, a pan-histone deacetylase inhibitor, in patients with lymphoma or multiple myeloma refractory to standard therapy.

artículo científico publicado en 2018

Phase II trial of concurrent chemoradiotherapy with L-asparaginase and MIDLE chemotherapy for newly diagnosed stage I/II extranodal NK/T-cell lymphoma, nasal type (CISL-1008)

artículo científico publicado en 2016

Phase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma study.

artículo científico publicado en 2009

Phase II trial of rituximab plus CVP combination chemotherapy for advanced stage marginal zone lymphoma as a first-line therapy: Consortium for Improving Survival of Lymphoma (CISL) study

artículo científico publicado en 2011

Plerixafor use for peripheral blood stem cell mobilization in Korea

artículo científico publicado en 2013

Polymorphic Region-Specific Antibody for Evaluation of Affinity-Associated Profile of Chimeric Antigen Receptor

scientific article published on 14 April 2020

Pomalidomide, cyclophosphamide, and dexamethasone for elderly patients with relapsed and refractory multiple myeloma: A study of the Korean Multiple Myeloma Working Party (KMMWP-164 study)

artículo científico publicado en 2020

Positive conversion of negative signaling of CTLA4 potentiates antitumor efficacy of adoptive T-cell therapy in murine tumor models

artículo científico publicado en 2012

Post-Transplantation Natural Killer Cell Count: A Predictor of Acute Graft-Versus-Host Disease and Survival Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation.

artículo científico publicado en 2016

Pralatrexate in patients with recurrent or refractory peripheral T-cell lymphomas: a multicenter retrospective analysis

artículo científico publicado en 2019

Prediction of survival by applying current prognostic models in diffuse large B-cell lymphoma treated with R-CHOP followed by autologous transplantation.

artículo científico publicado en 2015

Prevalence and Implications of Bone Marrow Involvement in Patients with Gastric Mucosa-Associated Lymphoid Tissue Lymphoma

artículo científico publicado en 2018

Prognostic Implications of Monosomies in Patients With Multiple Myeloma

artículo científico publicado en 2016

Prognostic Value of Platelet Count in Patients with Peripheral T Cell Lymphoma

scientific article published on 27 February 2019

Prognostic factors for re-mobilization using plerixafor and granulocyte colony-stimulating factor (G-CSF) in patients with malignant lymphoma or multiple myeloma previously failing mobilization with G-CSF with or without chemotherapy: the Korean mul

artículo científico

Prognostic role of the neutrophil-to-lymphocyte ratio in patients with primary central nervous system lymphoma

artículo científico publicado en 2017

Quantitative analysis of tumor-specific BCL2 expression in DLBCL: refinement of prognostic relevance of BCL2

scientific article published on 30 June 2020

R-CHOP chemoimmunotherapy followed by autologous transplantation for the treatment of diffuse large B-cell lymphoma

artículo científico publicado en 2014

Radiation therapy for gastric mucosa-associated lymphoid tissue lymphoma: dose-volumetric analysis and its clinical implications

artículo científico publicado en 2016

Rapid sequential gain of ABL1 kinase domain mutations with a complex karyotype in the progression of chronic myelogenous leukemia

artículo científico publicado en 2014

Reference intervals for circulating angiogenic cytokines

artículo científico publicado en 2008

Repeated radioimmunotherapy with 131I-rituximab for patients with low-grade and aggressive relapsed or refractory B cell non-Hodgkin lymphoma ⬇️

artículo científico publicado el 31 de enero de 2013

Retrospective comparison of bortezomib-containing regimens with vincristine-doxorubicin-dexamethasone (VAD) as induction treatment prior to autologous stem cell transplantation for multiple myeloma.

artículo científico publicado en 2009

Safety and effects of prophylactic defibrotide for sinusoidal obstruction syndrome in hematopoietic stem cell transplantation

artículo científico publicado el 28 de enero de 2013

Salvage therapy with gemcitabine, ifosfamide, dexamethasone, and oxaliplatin (GIDOX) for B-cell non-Hodgkin's lymphoma: a consortium for improving survival of lymphoma (CISL) trial

artículo científico publicado en 2009

Selection of a mobilization regimen for multiple myeloma based on the response to induction therapy: granulocyte-colony stimulating factor (G-CSF) alone versus high-dose cyclophosphamide plus G-CSF.

artículo científico publicado en 2015

Sequential vincristine, adriamycin, dexamethasone (VAD) followed by bortezomib, thalidomide, dexamethasone (VTD) as induction, followed by high-dose therapy with autologous stem cell transplant and consolidation therapy with bortezomib for newly dia

artículo científico publicado el 26 de julio de 2011

Serum and urine levels of interleukin-8 in patients with non-Hodgkin's lymphoma

artículo científico publicado en 2008

Somatic mutation of GNAQ gene is rare in common solid cancers and leukemias

artículo científico publicado en 2009

Somatic mutation of PIK3R1 gene is rare in common human cancers

artículo científico publicado en 2010

Somatic mutations of EGFR, ERBB2, ERBB3 and ERBB4 in juxtamembrane activating domains are rare in non-small cell lung cancers

artículo científico publicado en 2010

Stage IV marginal zone B-cell lymphoma--prognostic factors and the role of rituximab: Consortium for Improving Survival of Lymphoma (CISL) study

scientific article published on 01 November 2010

Statistics of hematologic malignancies in Korea: incidence, prevalence and survival rates from 1999 to 2008.

artículo científico publicado en 2012

T-Cell Receptor Rearrangements Determined Using Fragment Analysis in Patients With T-Acute Lymphoblastic Leukemia

scientific article published on 01 March 2019

T-cell P/E-selectin ligand alpha(1,3)fucosylation is not required for graft-vs-host disease induction

artículo científico publicado en 2005

Teaching NeuroImages: Periventricular restricted diffusion MRI in CMV ventriculitis

artículo científico publicado en 2015

The clinical impact of thalidomide maintenance after autologous stem cell transplantation in patients with newly diagnosed multiple myeloma in real clinical practice of Korea.

artículo científico publicado en 2016

The different roles of molecular classification according to upfront autologous stem cell transplantation in advanced-stage diffuse large B cell lymphoma patients with elevated serum lactate dehydrogenase

artículo científico publicado en 2016

The effectiveness and safety of lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma in real-world clinical practice: a study of the Korean Multiple Myeloma Working Party (KMMWP-151 study)

scientific article published on 23 December 2019

The host environment regulates the function of CD8+ graft-versus-host-reactive effector cells.

artículo científico publicado en 2008

The impact of upfront versus sequential use of bortezomib among patients with newly diagnosed multiple myeloma (MM): A joint analysis of the Singapore MM Study Group and the Korean MM Working Party for the Asian myeloma network ⬇️

artículo científico publicado el 28 de junio de 2013

The prognostic impact of inflammatory factors in patients with multiple myeloma treated with thalidomide in Korea

artículo científico publicado en 2015

Use of lenalidomide in the management of relapsed or refractory multiple myeloma: expert recommendations in Korea

artículo científico publicado en 2015

VEGFA and VEGFR2 genetic polymorphisms and survival in patients with diffuse large B cell lymphoma ⬇️

artículo científico publicado el 9 de enero de 2012

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda